中文名 | LMK 235 |
英文名 | LMK 235 |
别名 | HDAC抑制剂(LMK-235) N-[[6-(羟基氨基)-6-氧代己基]氧基]-3,5-二甲基-苯甲酰胺 |
英文别名 | LMK235 CS-1820 LMK 235 LMK-235 LMK 235 LMK-235 (Fandachem) N-[[6-(Hydroxyamino)-6-oxohexyl]oxy]-3,5-dimethyl-benzamide Benzamide, N-[[6-(hydroxyamino)-6-oxohexyl]oxy]-3,5-dimethyl- N-[[6-(Hydroxyamino)-6-oxohexyl]oxy]-3,5-dimethylbenzamide LMK-235 |
CAS | 1418033-25-6 |
EINECS | 808-770-7 |
化学式 | C15H22N2O4 |
分子量 | 294.35 |
InChIKey | VRYZCEONIWEUAV-UHFFFAOYSA-N |
密度 | 1.155±0.06 g/cm3(Predicted) |
熔点 | 135-138°C |
溶解度 | DMSO: 可溶20mg/mL,澄清 |
酸度系数 | 9.46±0.20(Predicted) |
存储条件 | 2-8°C |
外观 | 粉末 |
颜色 | white to beige |
产品用途 | LMK-235 is a selective histone deacetylase (HDAC) 4 and HDAC5 inhibitor. LMK-235 demonstrates activity against chemoresistant cancer cell lines in an MTT assay for cytotoxicity using human ovarian cancer cell lines A2780 and cisplatin resistant A2780CisR (IC50 = 0.49 and 0.32 μ M respectively). |
靶点 | HDAC4; HDAC5; |
危险品标志 | Xn - 有害物品 |
风险术语 | 22 - 吞食有害。 |
WGK Germany | 3 |
上游原料 | BENZYL 6-BROMOHEXANOATE |
参考资料 展开查看 | 1: Hansen FK, Sumanadasa SD, Stenzel K, Duffy S, Meister S, Marek L, Schmetter R, Kuna K, Hamacher A, Mordmüller B, Kassack MU, Winzeler EA, Avery VM, Andrews KT, Kurz T. Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages. Eur J Med Chem. 2014 Jul 23;82:204-13. doi: 10.1016/j.ejmech.2014.05.050. Epub 2014 May 22. PubMed PMID: 24904967. 2: Marek L, Hamacher A, Hansen FK, Kuna K, Gohlke H, Kassack MU, Kurz T. Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells. J Med Chem. 2013 Jan 24;56(2):427-36. doi: 10.1021/jm301254q. Epub 2013 Jan 8. PubMed PMID: 23252603. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.397 ml | 16.987 ml | 33.973 ml |
5 mM | 0.679 ml | 3.397 ml | 6.795 ml |
10 mM | 0.34 ml | 1.699 ml | 3.397 ml |
5 mM | 0.068 ml | 0.34 ml | 0.679 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!